发明名称 |
OPRF/I AGENTS AND THEIR USE IN HOSPITALIZED AND OTHER PATIENTS |
摘要 |
<p>The present invention relates to a new use of a vaccine comprising a fusion protein that comprises the Pseudomonas aeruginosa outer membrane protein I (OprI or OMPI) which is fused with its amino terminal end to the carboxy-terminal end of a carboxy-terminal portion of the Pseudomonas aeruginosa outer membrane protein F (OprF or OMPF), as well as to a new use of a monoclonal or polyclonal antibody against this fusion protein or a pharmaceutical composition thereof.</p> |
申请公布号 |
KR20130133212(A) |
申请公布日期 |
2013.12.06 |
申请号 |
KR20137015420 |
申请日期 |
2011.03.18 |
申请人 |
INTERCELL AUSTRIA AG |
发明人 |
KLADE CHRISTOPH;SCHLEGL ROBERT;WESTRITSCHNIG KERSTIN |
分类号 |
C07K14/21;A61K39/104;A61K39/40;C07K16/12;C07K19/00 |
主分类号 |
C07K14/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|